AstraZeneca Plans Major Investments Observing the 70th anniversary of its presence in Taiwan, pharmaceutical giant AstraZeneca announced plans to invest an additional NT$1 billion (over US$32 million) here in the next three years. AstraZeneca Taiwan president Simon Manners said the company will launch 10 new medicines by 2021, three of which have received priority approval…

Global and local firms are making new investments in semiconductor fabs in Taiwan. Taiwan is holding its own as a hub for semiconductor manufacturing, attracting steady new investment from chipmakers and other firms in the industry’s supply chain. The island manufactures about 25-30% of integrated circuits (ICs) globally and is home to Taiwan Semiconductor Manufacturing…

Taiwan’s chains are focusing on providing hyperlocal services in smaller spaces. Taiwan’s supermarkets in recent years have been morphing into a hybrid type all its own in response to the growing trend for consumers to prioritize convenience and service over huge product selection. In the past, Taiwanese consumers might patronize a department store once a…

IP violations remain a serious problem in Taiwan’s ultra-competitive chip-making market.    In recent years, trade-secret theft has become increasingly common in Taiwan’s highly competitive semiconductor industry, one of the world’s largest by output value and a bedrock of the island’s economy. The perpetrators have usually been Chinese companies seeking to close the technology gap with…